Vidium (9/13/2022)

CB Partner Webinar {{webinarsregistrationpage::webinar_title}} true {{webinarsregistrationpage::race_approved_pending}} 1 Credit Hour {{webinarsregistrationpage::hero_image}} {{webinarsregistrationpage::hero_image_self_hosted}} {{webinarsregistrationpage::hero_image_desktop_background_position}} {{webinarsregistrationpage::hero_image_mobile_background_position}} {{webinarsregistrationpage::hero_image_custom_padding}} {{webinarsregistrationpage::hero_image_custom_padding_mobile}} Vidium {{webinarsregistrationpage::supported_by}} {{webinarsregistrationpage::multiple_speakers}}

In this webinar, explore the clinical applications of cancer genomics in canine osteosarcoma. Dr. Esther Chon will provide an overview on osteosarcoma, how to incorporate genomics into daily clinical practice, and how genomic findings can expand treatment options for osteosarcoma management. Olaparib, the second drug in Vidum’s series of targeted therapies, will also be discussed.

{{webinarsregistrationpage::inside_the_webinar_2}} {{webinarsregistrationpage::inside_the_webinar_3}} How to incorporate genomics into daily clinical practice The utility of genomic information in the management of canine osteosarcoma The canine-specific information for olaparib, the second drug in Vidum’s series of targeted therapies {{webinarsregistrationpage::what_youll_learn_bullet_4}} {{webinarsregistrationpage::what_youll_learn_bullet_5}} {{webinarsregistrationpage::what_youll_learn_bullet_6}} {{webinarsregistrationpage::additional_subhead}} {{webinarsregistrationpage::additional_copy}} In adherence with RACE guidelines, CE certificates can only be distributed to individual registrants under the name used upon registration. Group viewers will not be eligible to receive multiple CE certificates.